Glyphic Biotechnologies
New York, NY
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
glyphic.bioCompany Details
Founded
- 2021
Employees
- Between 10 - 50 employees
Raised
- $7,783,799
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Joshua Yang
Founders
- Joshua YangDaniel Estandian
Company Collections
These are collections Glyphic Biotechnologies is a part of. Click on the collection name to view similar companies.
Glyphic Biotechnologies' Industries
Current Job Listings
Glyphic Biotechnologies Headquarters Location
Total Amount Raised: $7,783,799
Glyphic Biotechnologies Funding Rounds
Grant
$408,939
Grant Investors
National Institutes of Health (NIH)Grant
$358,981
Grant Investors
National Institutes of Health (NIH)Grant
$390,584
Grant Investors
National Institutes of Health (NIH)Grant
$100,000
Grant Investors
Johnson & Johnson Robotics and Digital SolutionsGrant
$409,295
Grant Investors
National Institutes of Health (NIH)Grant
$1,000
Grant
$40,000
Grant Investors
QIAGENGrant
$50,000
Grant Investors
Johnson & Johnson Robotics and Digital SolutionsPre Seed
$6,025,000
Pre Seed Investors
OMX VenturesCantos VenturesCivilization VenturesWing Venture ManagementAxialOsage University Partners IIArtis Ventures
Glyphic Biotechnologies Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Glyphic Biotechnologies.